Breast Biopsy Market
Breast Biopsy Market Size, Share & Trends Analysis by Type (Fine Needle Biopsy, Core Needle Biopsy, Surgical Biopsy, and Others (Lymph Node and Vacuum-Assisted Biopsy), By Product (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kit, and Other), By Guided Technology (MRI-Guided Biopsy, Ultrasound-Guided Biopsy, Mammography Guided Stereotactic Biopsy, CT-Guided Biopsy and Other), By End-User (Hospitals, Diagnostic Centre, and Research Institute), Forecast Period (2026-2035)
Industry Overview
Breast biopsy market was valued at $2.4 billion in 2025 and is projected to reach $4.3 billion by 2035, growing at a CAGR of 6.2% during the forecast Period (2026-2035). The market growth is driven by rising breast cancer rates, greater awareness leading to more screenings, and tech advancements in imaging-guided, minimally invasive techniques (VABB) for better accuracy and patient comfort, with key players focusing on innovation.
Market Dynamics
Rising Detection Rates and Expanding Screening Programs
Wider uptake of mammography (including digital mammography and tomosynthesis), growing use of breast MRI in high-risk populations, and overall rising breast cancer incidence in many regions are increasing the number of lesions that require tissue diagnosis. That higher screening throughput directly raises demand for biopsy procedures, particularly image-guided, minimally invasive techniques, and expands volumes for both devices and single-use disposables. Increased detection also drives the need for higher-yield sampling (fewer repeat procedures), favoring vacuum-assisted and advanced core-needle systems.
Technology and Imaging-Workflow Integration
Ongoing innovation, better imaging guidance (3D tomosynthesis, enhanced ultrasound, MRI guidance), more precise vacuum-assisted and directional biopsy devices, and integration between imaging platforms and biopsy tools improve diagnostic accuracy and efficiency. When manufacturers deliver streamlined image-to-biopsy workflows, clinicians can obtain larger, higher-quality tissue samples with fewer passes and less procedure time, which both improves clinical outcomes and encourages hospitals and outpatient centers to adopt newer systems. This creates a replacement and upgrade cycle that supports device and consumable revenue growth.
Reimbursement, Cost Pressures, and Shift to Outpatient Care
Reimbursement policies that favor image-guided, minimally invasive procedures promote the adoption of percutaneous biopsy over surgical excision, while healthcare cost containment pushes providers to choose solutions that shorten procedure time and reduce downstream costs (repeat biopsies, complications). At the same time, a move from operating rooms to clinic- or radiology-suite settings increases demand for portable, easy-to-use systems and single-use disposables. Together, reimbursement incentives and value-based purchasing accelerate migration to lower-cost, high-throughput biopsy technologies and business models (capital sales plus recurring consumables).
Market Segmentation
- Based on the type, the market is segmented into fine needle biopsy, core needle biopsy, surgical biopsy, and others (lymph node and vacuum-assisted biopsy).
- Based on the product, the market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kit, and other.
- Based on the guided technology, the market is segmented into MRI-guided biopsy, ultrasound-guided biopsy, mammography-guided stereotactic biopsy, CT-guided biopsy and other.
- Based on the end-user, the market is segmented into hospitals, diagnostic centre, and research institute.
Core Needle Biopsy (CNB) Segment to Grow at a Considerable Market Share
Core needle biopsy (CNB) under the type category represents the largest and leading segment in the global breast biopsy market. The dominance of core needle biopsy is primarily driven by its high diagnostic accuracy, minimally invasive nature, and ability to provide sufficient tissue samples for histopathological and molecular analysis compared to fine needle biopsy. CNB is widely adopted as the standard of care for suspicious breast lesions detected through screening programs, as it offers a strong balance between procedural safety and clinical reliability while avoiding the higher costs and patient discomfort associated with surgical biopsy.
The growing global incidence of breast cancer, coupled with increasing awareness and early detection initiatives, has further accelerated the preference for core needle biopsy across hospitals and diagnostic centers. Additionally, advancements in image-guided technologies, particularly ultrasound- and stereotactic-guided core biopsies, have improved procedural precision and patient outcomes, reinforcing the segment’s leadership. As healthcare systems increasingly emphasize outpatient procedures, cost-effectiveness, and faster diagnosis, core needle biopsy continues to command the largest market share and is expected to maintain its leading position throughout the forecast period.
Biopsy Needles: A Key Segment in Market Growth
In the global breast biopsy market, the biopsy needles segment under the product category is witnessing the highest growth and is considered the key segment driving market expansion. Biopsy needles, including fine-needle aspiration and core-needle biopsy types, are widely preferred due to their minimally invasive nature, high diagnostic accuracy, and cost-effectiveness. The growing emphasis on early detection of breast cancer and the increasing prevalence of breast malignancies worldwide have significantly boosted the demand for biopsy needles.
Additionally, advancements in needle technology, such as vacuum-assisted and automated core-needle systems, have improved procedural efficiency and patient comfort, further reinforcing their market dominance. Healthcare providers, including hospitals and diagnostic centers, are increasingly adopting these needles due to their ease of use in outpatient and minimally invasive settings, reducing the need for surgical intervention. Moreover, rising awareness campaigns for breast cancer screening and preventive healthcare measures across key regions such as North America and Europe are fueling higher utilization rates of biopsy needles.
Regional Outlook
The global breast biopsy market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Region to Hold a Substantial Growth Rate
In North America, the US dominates the global breast biopsy market,, holding a major share due to its advanced healthcare infrastructure, high prevalence of breast cancer, and widespread adoption of innovative biopsy technologies. The US healthcare system emphasizes early cancer detection and preventive care, driving significant demand for breast biopsy procedures. Availability of state-of-the-art diagnostic tools, including MRI-guided, ultrasound-guided, and stereotactic biopsy systems, has enhanced procedural accuracy and efficiency, encouraging hospitals and diagnostic centers to increasingly adopt these technologies.
Furthermore, the presence of leading market players such as Hologic, Siemens Healthineers, GE Healthcare, and Becton Dickinson in the country has accelerated product innovation and accessibility, strengthening the US market position. Government initiatives and awareness programs promoting breast cancer screening, combined with high healthcare expenditure per capita, have further contributed to the country’s dominance. In addition, reimbursement policies for minimally invasive diagnostic procedures support higher procedure volumes, benefiting the market growth. The combination of technological advancements, supportive regulatory frameworks, and a strong patient awareness ecosystem ensures that the United States continues to lead the global breast biopsy market, setting a benchmark for other regions to follow in adoption and utilization rates.
Market Players Outlook
The major companies operating in the global breast biopsy market include Argon Medical Devices, Inc., Becton, Dickinson and Co.(BD), Danaher Corp., Hologic, Inc., Merit Medical Systems, Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their businesses and develop innovative products to maintain their market positioning.
Recent Development
- In December 2025, skipping sentinel lymph node biopsy (SLNB) in clinically node-negative, HR-positive, HER2-negative early-stage breast cancer patients did not affect regional control or survival, as shown in a study of 1,733 patients. After a median follow-up of five years, cancer recurrence in lymph nodes was observed in 0.5% of the SLNB group compared to 1.2% for those who omitted SLNB, with no statistically significant difference. The five-year regional recurrence-free survival rates were also similar: 96.6% for the SLNB group versus 94.2% for the SLNB-omitted group.
- In October 2025, the Radiology department at the University of Chicago Medicine launched an initiative to offer same-day breast biopsies, making it the only hospital in the Chicago area to do so. This program, initiated on September 15, allows immediate scheduling of patient consultations with breast cancer surgeons post-imaging. Key improvements include the creation of a new work order for OB-GYNs and primary care physicians, enabling breast radiologists to initiate additional tests independently. The department has also adjusted staff schedules and hired a breast cancer nurse navigator to enhance the efficiency of the process.
- In May 2025, Stratipath enhanced its CE-IVD-marked AI diagnostic solution, Stratipath Breast, to include biopsy capability, allowing for analysis of core needle biopsies in addition to resected tumors. This deep learning tool assesses H&E-stained slides to classify invasive early-stage breast cancers into risk levels within one hour, aiding decision-making for neoadjuvant chemotherapy. It provides an independent risk stratification alternative when traditional histological grading is inconsistent, particularly benefiting patients with ER+, triple-negative, and HER2+ breast cancer by informing tailored treatment approaches.
The Report Covers
- Market value data analysis for 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global breast biopsy market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Breast Biopsy Market Sales Analysis – Type | Product | Guided Technology | End-User ($ Million)
- Breast Biopsy Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Breast Biopsy Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Breast Biopsy Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Breast Biopsy Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Breast Biopsy Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Breast Biopsy Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Breast Biopsy Market Revenue and Share by Manufacturers
- Breast Biopsy Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Argon Medical Devices, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Becton, Dickinson and Co.(BD)
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Danaher Corp.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Hologic, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Merit Medical Systems, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Argon Medical Devices, Inc.
- Key Company Analysis
- Global Breast Biopsy Market Sales Analysis by Type ($ Million)
- Fine Needle Biopsy
- Core Needle Biopsy
- Surgical Biopsy
- Others (Lymph Node and Vacuum Assisted Biopsy)
- Global Breast Biopsy Market Sales Analysis by Product ($ Million)
- Biopsy Needles
- Guidance Systems
- Biopsy Tables
- Localization Wires
- Assay Kit
- Others
- Global Breast Biopsy Market Sales Analysis by Guided Technology ($ Million)
- MRI-Guided Biopsy
- Ultrasound Guided Biopsy
- Mammography Guided Stereotactic Biopsy
- CT-Guided Biopsy
- Others
- Global Breast Biopsy Market Sales Analysis by End-User ($ Million)
- Hospitals
- Diagnostic Centre
- Research Institute
- Regional Analysis
- North American Breast Biopsy Market Sales Analysis – Type | Product | Guided Technology | End-User | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Breast Biopsy Market Sales Analysis – Type | Product | Guided Technology | End-User | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Breast Biopsy Market Sales Analysis – Type | Product | Guided Technology | End-User | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Breast Biopsy Market Sales Analysis – Type | Product | Guided Technology | End-User | Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Abbott Laboratories, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Argon Medical Devices, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Braun Melsungen AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Becton, Dickinson and Co. (BD)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Boston Scientific Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cardinal Health, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cook Medical, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Danaher Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hoffmann-La Roche Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Fujifilm Holdings Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GE HealthCare Technologies Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hologic, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Illumina, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medtronic plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merit Medical Systems, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Planmed Oy
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Qiagen N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Siemens Healthineers AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- STERYLAB S.r.l.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott Laboratories, Inc.
1. Global Breast Biopsy Market Research and Analysis by Type, 2025–2035 ($ Million)
2. Global Fine Needle Biopsy Market Research And Analysis By Region, 2025–2035 ($ Million)
3. Global Core Needle Biopsy Market Research And Analysis By Region, 2025–2035 ($ Million)
4. Global Surgical Biopsy Market Research And Analysis By Region, 2025–2035 ($ Million)
5. Global Other Type Biopsy Market Research And Analysis By Region, 2025–2035 ($ Million)
6. Global Breast Biopsy Market Research and Analysis by Product, 2025–2035 ($ Million)
7. Global Biopsy Needles Market Research And Analysis By Region, 2025–2035 ($ Million)
8. Global Guidance Systems For Biopsy Market Research And Analysis By Region, 2025–2035 ($ Million)
9. Global Biopsy Tables Market Research And Analysis By Region, 2025–2035 ($ Million)
10. Global Localization Wires For Biopsy Market Research And Analysis By Region, 2025–2035 ($ Million)
11. Global Assay Kit For Biopsy Market Research And Analysis By Region, 2025–2035 ($ Million)
12. Global Other Product Type Biopsy Market Research And Analysis By Region, 2025–2035 ($ Million)
13. Global Breast Biopsy Market Research and Analysis by Guided Technology, 2025–2035 ($ Million)
14. Global MRI-Guided Biopsy Market Research And Analysis By Region, 2025–2035 ($ Million)
15. Global Ultrasound Guided Biopsy Market Research And Analysis By Region, 2025–2035 ($ Million)
16. Global Mammography Guided Stereotactic Biopsy Market Research And Analysis By Region, 2025–2035 ($ Million)
17. Global CT-Guided Biopsy Market Research And Analysis By Region, 2025–2035 ($ Million)
18. Global Other Guided Biopsy Market Research And Analysis By Region, 2025–2035 ($ Million)
19. Global Breast Biopsy Market Research and Analysis by End-User, 2025–2035 ($ Million)
20. Global Breast Biopsy For Hospitals Market Research And Analysis By Region, 2025–2035 ($ Million)
21. Global Breast Biopsy For Diagnostic Centre Market Research And Analysis By Region, 2025–2035 ($ Million)
22. Global Breast Biopsy For Research Institute Market Research And Analysis By Region, 2025–2035 ($ Million)
23. Global Breast Biopsy Market Research and Analysis by Region, 2025–2035 ($ Million)
24. North American Breast Biopsy Market Research and Analysis by Type, 2025–2035 ($ Million)
25. North American Breast Biopsy Market Research and Analysis by Product, 2025–2035 ($ Million)
26. North American Breast Biopsy Market Research and Analysis by Guided Technology, 2025–2035 ($ Million)
27. North American Breast Biopsy Market Research and Analysis by End-User, 2025–2035 ($ Million)
28. European Breast Biopsy Market Research and Analysis by Type, 2025–2035 ($ Million)
29. European Breast Biopsy Market Research and Analysis by Product, 2025–2035 ($ Million)
30. European Breast Biopsy Market Research and Analysis by Guided Technology, 2025–2035 ($ Million)
31. European Breast Biopsy Market Research and Analysis by End-User, 2025–2035 ($ Million)
32. Asia-Pacific Breast Biopsy Market Research and Analysis by Type, 2025–2035 ($ Million)
33. Asia-Pacific Breast Biopsy Market Research and Analysis by Product, 2025–2035 ($ Million)
34. Asia-Pacific Breast Biopsy Market Research and Analysis by Guided Technology, 2025–2035 ($ Million)
35. Asia-Pacific Breast Biopsy Market Research and Analysis by End-User, 2025–2035 ($ Million)
36. Rest of the World Breast Biopsy Market Research and Analysis by Region, 2025–2035 ($ Million)
37. Rest of the World Breast Biopsy Market Research and Analysis by Type, 2025–2035 ($ Million)
38. Rest of the World Breast Biopsy Market Research and Analysis by Product, 2025–2035 ($ Million)
39. Rest of the World Breast Biopsy Market Research and Analysis by Guided Technology, 2025–2035 ($ Million)
40. Rest of the World Breast Biopsy Market Research and Analysis by End-User, 2025–2035 ($ Million)
1. Global Breast Biopsy Market Share By Type, 2025 Vs 2035 (%)
2. Global Fine Needle Biopsy Market Share By Region, 2025 Vs 2035 (%)
3. Global Core Needle Biopsy Market Share By Region, 2025 Vs 2035 (%)
4. Global Surgical Biopsy Market Share By Region, 2025 Vs 2035 (%)
5. Global Other Type Biopsy Market Share By Region, 2025 Vs 2035 (%)
6. Global Breast Biopsy Market Share By Product, 2025 Vs 2035 (%)
7. Global Biopsy Needles Market Share By Region, 2025 Vs 2035 (%)
8. Global Guidance Systems For Biopsy Market Share By Region, 2025 Vs 2035 (%)
9. Global Biopsy Tables Market Share By Region, 2025 Vs 2035 (%)
10. Global Localization Wires For Biopsy Market Share By Region, 2025 Vs 2035 (%)
11. Global Assay Kit For Biopsy Market Share By Region, 2025 Vs 2035 (%)
12. Global Other Product Type Biopsy Market Share By Region, 2025 Vs 2035 (%)
13. Global Breast Biopsy Market Share By Guided Technology, 2025 Vs 2035 (%)
14. Global MRI-Guided Biopsy Market Share By Region, 2025 Vs 2035 (%)
15. Global Ultrasound-Guided Biopsy Market Share By Region, 2025 Vs 2035 (%)
16. Global Mammography-Guided Stereotactic Biopsy Market Share By Region, 2025 Vs 2035 (%)
17. Global CT-Guided Biopsy Market Share By Region, 2025 Vs 2035 (%)
18. Global Other Guided Biopsy Market Share By Region, 2025 Vs 2035 (%)
19. Global Breast Biopsy Market Share By End-User, 2025 Vs 2035 (%)
20. Global Breast Biopsy For Hospitals Market Share By Region, 2025 Vs 2035 (%)
21. Global Breast Biopsy For Diagnostic Centre Market Share By Region, 2025 Vs 2035 (%)
22. Global Breast Biopsy For Research Institute Market Share By Region, 2025 Vs 2035 (%)
23. Global Breast Biopsy Market Share By Region, 2025 Vs 2035 (%)
24. US Breast Biopsy Market Size, 2025–2035 ($ Million)
25. Canada Breast Biopsy Market Size, 2025–2035 ($ Million)
26. UK Breast Biopsy Market Size, 2025–2035 ($ Million)
27. France Breast Biopsy Market Size, 2025–2035 ($ Million)
28. Germany Breast Biopsy Market Size, 2025–2035 ($ Million)
29. Italy Breast Biopsy Market Size, 2025–2035 ($ Million)
30. Spain Breast Biopsy Market Size, 2025–2035 ($ Million)
31. Russia Breast Biopsy Market Size, 2025–2035 ($ Million)
32. Rest of Europe Breast Biopsy Market Size, 2025–2035 ($ Million)
33. India Breast Biopsy Market Size, 2025–2035 ($ Million)
34. China Breast Biopsy Market Size, 2025–2035 ($ Million)
35. Japan Breast Biopsy Market Size, 2025–2035 ($ Million)
36. South Korea Breast Biopsy Market Size, 2025–2035 ($ Million)
37. Australia and New Zealand Breast Biopsy Market Size, 2025–2035 ($ Million)
38. ASEAN Economies Breast Biopsy Market Size, 2025–2035 ($ Million)
39. Rest of Asia-Pacific Breast Biopsy Market Size, 2025–2035 ($ Million)
40. Latin America Breast Biopsy Market Size, 2025–2035 ($ Million)
41. Middle East and Africa Breast Biopsy Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Breast Biopsy Market in 2025 is estimated to be around $2.4 billion.
North America holds the largest share in the Breast Biopsy Market.
Leading players in the Breast Biopsy Market include Argon Medical Devices, Inc., Becton, Dickinson and Co.(BD), Danaher Corp., Hologic, Inc., Merit Medical Systems, Inc., among others.
The Breast Biopsy Market is expected to grow at a CAGR of 6.2% from 2026 to 2035.
The Breast Biopsy Market is driven by rising breast cancer prevalence and increasing demand for early and accurate diagnostic procedures.
